139 related articles for article (PubMed ID: 11489729)
21. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.
Bebermeier JH; Brooks JD; DePrimo SE; Werner R; Deppe U; Demeter J; Hiort O; Holterhus PM
J Mol Med (Berl); 2006 Nov; 84(11):919-31. PubMed ID: 16932916
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
23. Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators.
Yeh S; Chang HC; Miyamoto H; Takatera H; Rahman M; Kang HY; Thin TH; Lin HK; Chang C
Keio J Med; 1999 Jun; 48(2):87-92. PubMed ID: 10405524
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
[TBL] [Abstract][Full Text] [Related]
25. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
[TBL] [Abstract][Full Text] [Related]
26. High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer.
Fancher AT; Hua Y; Camarco DP; Close DA; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2018; 16(6):297-319. PubMed ID: 30109944
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells.
Rahman MM; Miyamoto H; Lardy H; Chang C
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5124-9. PubMed ID: 12700349
[TBL] [Abstract][Full Text] [Related]
28. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer.
Mori R; Wang Q; Quek ML; Tarabolous C; Cheung E; Ye W; Groshen S; Hawes D; Togo S; Shimada H; Danenberg KD; Danenberg PV; Pinski JK
Anticancer Res; 2008; 28(1B):425-30. PubMed ID: 18383880
[TBL] [Abstract][Full Text] [Related]
31. Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen.
Fancher AT; Hua Y; Camarco DP; Close DA; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2016 Oct; 14(8):453-477. PubMed ID: 27606620
[TBL] [Abstract][Full Text] [Related]
32. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
Miyamoto H; Rahman M; Takatera H; Kang HY; Yeh S; Chang HC; Nishimura K; Fujimoto N; Chang C
J Biol Chem; 2002 Feb; 277(7):4609-17. PubMed ID: 11673464
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells.
Heemers HV; Schmidt LJ; Kidd E; Raclaw KA; Regan KM; Tindall DJ
Prostate; 2010 Jun; 70(9):959-70. PubMed ID: 20166126
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
36. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
[TBL] [Abstract][Full Text] [Related]
37. Bone stroma-derived cells change coregulators recruitment to androgen receptor and decrease cell proliferation in androgen-sensitive and castration-resistant prostate cancer cells.
Villagran MA; Gutierrez-Castro FA; Pantoja DF; Alarcon JC; Fariña MA; Amigo RF; Muñoz-Godoy NA; Pinilla MG; Peña EA; Gonzalez-Chavarria I; Toledo JR; Rivas CI; Vera JC; McNerney EM; Onate SA
Biochem Biophys Res Commun; 2015 Nov; 467(4):1039-45. PubMed ID: 26494300
[TBL] [Abstract][Full Text] [Related]
38. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer.
Li P; Yu X; Ge K; Melamed J; Roeder RG; Wang Z
Am J Pathol; 2002 Oct; 161(4):1467-74. PubMed ID: 12368219
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor coregulators NOCR1, TIF2, and ARA70 may account for the hydroxyflutamide insensitivity of prostate cancer cells.
Wang Y; Li JQ; Shao C; Shi CH; Liu F; Yang ZY; Qiu JX; Li YM; Fu Q; Zhang W; Xue W; Lei YH; Gao JY; Wang JY; Gao XP; Yuan JL; Bao TY; Zhang YT
Ir J Med Sci; 2011 Dec; 180(4):865-72. PubMed ID: 21748440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
